As program manager for the Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), my work focuses on the value of new technologies and how to most effectively and efficiently implement them into health care, with a particular focus on personalized (or precision) medicine...
Every day, on average, ten new genetic tests become commercially available to help doctors and patients make more informed decisions about health care.
My work focuses on the translation of new technologies into improved patient outcomes, particularly the translation of personalized/precision medicine—targeting health care interventions to patients based on their genetics—into clinical care and health policy.
